Today: 29 April 2026
HSBC share price slips in early London trade as tariff jitters hit risk mood
19 January 2026
1 min read

HSBC share price slips in early London trade as tariff jitters hit risk mood

London, Jan 19, 2026, 08:01 GMT — Regular session

  • HSBC shares dropped roughly 1.2% at the open, following the weaker risk sentiment across Europe.
  • With U.S. cash markets closed for a holiday, investors weighed new U.S. tariff threats targeting European countries.
  • Investors are eyeing HSBC’s strategic review of its Singapore insurance unit as the bank prepares to release annual results on Feb. 25.

HSBC shares dropped 1.2% to 1,216.9 pence just after London markets opened at 0801 GMT.

The decline hit as global markets opened lower, following U.S. President Donald Trump’s threat of new tariffs targeting multiple European nations, rattling sentiment ahead of the European open.

U.S. equity and bond markets will be closed Monday in observance of Martin Luther King Jr. Day, leading to lighter global liquidity and fewer cues throughout the day.

Trump announced plans to slap extra import levies on products from eight European countries starting Feb. 1, Reuters reported. If no agreement is reached by June 1, those tariffs would increase.

Deutsche Bank analysts flagged that the greater market threat might stem from financial connections rather than trade alone. George Saravelos, the bank’s global head of FX research, said, “It is a weaponisation of capital rather than trade flows that would by far be the most disruptive to markets.” Reuters

HSBC is juggling several strategic moves. The bank is considering selling its insurance business in Singapore, according to analysts cited by the South China Morning Post. This comes as HSBC reallocates resources to boost its insurance operations in Hong Kong and mainland China.

“It makes sense for HSBC to consider an exit from Singapore’s insurance market to focus on Hong Kong and mainland China,” Kenny Tang Sing-hing, chairman of the Hong Kong Institute of Financial Analysts and Professional Commentators, told the newspaper. South China Morning Post

Bank investors remain focused on the macro environment, which largely drives daily performance. Expectations around interest rates are crucial—they influence net interest margin, the gap between what banks earn on loans versus what they pay on deposits. This margin can shift rapidly as bond yields fluctuate.

That said, downside risks remain evident. A prolonged tariff dispute might dampen corporate activity and cross-border transactions. Meanwhile, any move to sell assets in Singapore would spark debate among investors over valuation, capital returns, and the distribution network the bank might forfeit.

Wall Street remains closed until Tuesday, leaving London traders to gauge how far the risk jitters stretch through the European session. They’ll also be watching to see if HSBC faces more selling pressure after the initial drop.

Stock Market Today

  • Qualcomm Q2 Earnings Preview Amid Smartphone Market Downturn
    April 29, 2026, 1:07 PM EDT. Qualcomm is set to report second-quarter earnings amid a sharp downturn in the global smartphone market. The company, known for its smartphone chips, faces challenges as shipments fell 4.1% in Q1, marking an end to a 10-quarter growth streak. Analyst Ming-Chi Kuo highlights Qualcomm's upcoming AI chip with OpenAI, aiming for mass production in 2028 to challenge Apple and Google's dominance. Despite diversification into data centers and automotive sectors, the handset division, driving most revenue, is expected to drop 12.5% year-over-year. Qualcomm forecasts Q2 revenue of $10.56 billion and earnings per share of $2.55, down from last year. CEO Cristiano Amon's upcoming keynote could shed light on the company's AI and data center strategies amid this challenging market.

Latest article

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Tel Aviv, April 29, 2026, 20:03 (IDT) Teva Pharmaceutical Industries’ New York-listed shares rose sharply on Wednesday after the Israel-based drugmaker beat first-quarter profit expectations, helped by a faster shift toward branded medicines and away from lower-margin generics. The move gave investors a clearer test of Chief Executive Richard Francis’s turnaround plan, not just another quarter of cost cuts. The timing matters because Teva’s three key growth drugs — Austedo for movement disorders, Ajovy for migraine and Uzedy for schizophrenia — are now doing more of the work once expected from its generics engine. Teva said the three brands generated
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

Starbucks Stock Surges After Earnings Beat Makes Niccol’s Turnaround Look Real

29 April 2026
Starbucks raised its fiscal 2026 outlook after global comparable store sales rose 6.2% in the second quarter, beating analyst estimates. Shares jumped about 10% to $107.03. North American operating margin fell to 9.9% from 11.6% due to higher labor and product costs. The company now expects at least 5% comparable sales growth for the year.
Global Unichip (3443) stock slips after record high — what investors are watching next
Previous Story

Global Unichip (3443) stock slips after record high — what investors are watching next

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Next Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

Go toTop